Coeptis Therapeutics, Inc. Increase (Decrease) in Deferred Revenue
Coeptis Therapeutics, Inc. reported Increase (Decrease) in Deferred Revenue of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2022-11-08
- Coeptis Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2021-12-31 was $0.00.
- Coeptis Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2021 was -$1.00M, a 300.00% decline from fiscal 2020.
- Coeptis Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2020 was $500.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$1.00M 10-K · filed 2022-03-11 | |
| 2021-09-30 | -$1.00M 10-Q · filed 2022-11-08 | ||
| 2020-12-31 | $500.00K 10-K · filed 2022-03-11 |